Company Filing History:
1 out of 64 
1 out of 101 Years Active: 2017
Title: Moshe Hosen: Innovator in Ovarian Cancer Prognosis
Introduction
Moshe Hosen is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of cancer research, particularly in the prognosis of ovarian cancer. His innovative work has the potential to improve the lives of many patients facing this challenging disease.
Latest Patents
Moshe Hosen holds a patent for "Compositions and methods for prognosis of ovarian cancer." This invention describes compositions and methods for predicting the prognosis of ovarian cancer subjects. It provides methods for distinguishing between histological subtypes of ovarian cancer tumors, as well as methods and compositions for the treatment or prevention of ovarian cancer. Specifically, the invention relates to microRNA molecules associated with these methods and compositions, along with various nucleic acid molecules related to or derived from them. He has 1 patent to his name.
Career Highlights
Throughout his career, Moshe Hosen has worked with prominent companies in the biotechnology sector. He has been associated with Rosetta Genomics Ltd. and Mor Research Applications Ltd. His work in these organizations has furthered the understanding and treatment of ovarian cancer.
Collaborations
Moshe has collaborated with notable colleagues, including Gila Lithwick Yanai and Ram Eitan. These partnerships have contributed to the advancement of research in his field.
Conclusion
Moshe Hosen's innovative contributions to ovarian cancer prognosis highlight his dedication to improving patient outcomes. His work continues to inspire advancements in cancer research and treatment.